Bayer Schering Leader Outlines Plans To Integrate Chinese Scientists Into Worldwide Research, Exchanges: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
Chris Lee, the Asia-Pacific regional head for Bayer Schering Pharma, recently discussed with the China Bureau of PharmAsia News the German-headquartered outfit's plans to expand exchanges between scientists at its new R&D center in Beijing and other Bayer research outposts, and projections that China will be a global growth driver into the future (PharmAsia News, Feb.19, 2009).
You may also be interested in...
Bayer Shifting Further To Emerging Markets Including China
Already a big player in the world's largest pharmemerging market, China, Bayer is plunging deeper and reallocating more resources in capital investment and manpower to emerging markets
Bayer Shifting Further To Emerging Markets Including China
Already a big player in the world's largest pharmemerging market, China, Bayer is plunging deeper and reallocating more resources in capital investment and manpower to emerging markets
As Financial Turmoil Engulfs West, Germany’s Bayer Looks East To Form R&D Center In Rising China
BEIJING - German pharmaceutical powerhouse Bayer Schering is engineering an alliance with Chinese scientists to create a global research and development center in Beijing, according to senior Bayer executives